Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
April 29, 2021 05:13 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...
Worldwide Eye Care Industry to 2026 - Players Include Alcon, Allergan and Essilor Luxottica Among Others
March 31, 2021 05:03 ET
|
Research and Markets
Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Global Eye Care Market, By Product Type (Eyeglasses, Contact Lens, Intraocular Lens, Eye Drops, Others), By Coating (Anti-Glare, UV coating, Others),...
Global Eyewear Market is estimated to account for US$ 461.60 Bn by end of 2027, Says Coherent Market Insights (CMI)
March 17, 2021 08:30 ET
|
CMI
SEATTLE, March 17, 2021 (GLOBE NEWSWIRE) -- Eyewear consists of items and accessories worn on or over the eyes to enhance or improve visual acuity. It is a corrective or protective device for the...
Cross Keys Capital Advises on Community Eye Center's Partnership with Quigley Eye Specialists
January 19, 2021 11:30 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Community Eye Center, P.A., Community Eye Optical, L.C., and St. Lucy’s Eye...
Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
December 15, 2020 01:15 ET
|
Novartis International AG
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52)1In a...
Cross Keys Capital Advises Retina Associates of Sarasota on Their Partnership with Retina Consultants of America
November 18, 2020 15:44 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Retina Associates of Sarasota (RAS) in its partnership with Retina...
Global Lazy Eye (Amblyopia) Market Outlook Report 2019-2020 & 2027 Featuring Vivid Vision, TCI Chemicals, Rebion, Pfizer, JnJ, Bausch & Lomb & Adwia Pharma
October 30, 2020 05:43 ET
|
Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Lazy Eye - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. According to the report, the Global Lazy...
US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET
|
Novartis International AG
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients1 The...
Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye”
April 20, 2020 01:17 ET
|
Novartis International AG
Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults1Acquisition expands the Novartis refractive disorder pipeline in...
Cross Keys Capital Advises Lehigh Valley Eye Center and Valley Eye Surgical Center on Their Partnership with Spectrum Vision Partners
March 31, 2020 19:32 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, FL, March 31, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Lehigh Valley Eye Center, PC ("LVEC") and SLTLBK Associates, LLC dba Valley Eye...